Pulmonary paracoccidioidomycosis : a case report of reactivation in a patient receiving biological therapy

Paracoccidioidomycosis is an endemic disease in Latin America that is rarely associated with immunosuppression and biological therapy. Herein, we report for the first time a case of pulmonary paracoccidioidomycosis reactivation after infliximab treatment. A 47-year-old man from Brazil received infliximab to treat psoriatic spondyloarthropathy and presented with cough, dyspnea, weight loss, and fever. Chest computed tomography revealed a pulmonary nodule and biopsy confirmed paracoccidioidomycosis. Treatment with sulfamethoxazole and trimethoprim was initiated for fungal infection and infliximab was reintroduced two months later. Considering his clinical improvement and favorable radiologic evolution, antifungal therapy was discontinued after 29 months.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:51

Enthalten in:

Revista da Sociedade Brasileira de Medicina Tropical - 51(2018), 2 vom: 14. März, Seite 249-252

Sprache:

Englisch

Beteiligte Personen:

Covre, Lúcia Carla Polaco [VerfasserIn]
Hombre, Pâmela Mazzini [VerfasserIn]
Falqueto, Aloísio [VerfasserIn]
Peçanha, Paulo Mendes [VerfasserIn]
Valim, Valéria [VerfasserIn]

Links:

Volltext

Themen:

Antirheumatic Agents
B72HH48FLU
Case Reports
Infliximab

Anmerkungen:

Date Completed 24.05.2018

Date Revised 24.05.2018

published: Print

Citation Status MEDLINE

doi:

10.1590/0037-8682-0222-2017

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM284148423